An open label study to evaluate the colesevelam HCL for accelerated elimination of teriflunomide, and monitoring of teriflunomide concentration using dried blood spot assay.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2017
At a glance
- Drugs Colesevelam (Primary) ; Teriflunomide
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Jan 2017 Results published in the Journal of Clinical Pharmacology.
- 21 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.